ClinVar Miner

Submissions for variant NM_000173.7(GP1BA):c.344T>C (p.Leu115Pro) (rs1597638598)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
NIHR Bioresource Rare Diseases, University of Cambridge RCV000851640 SCV000899680 likely pathogenic Thrombocytopenia 2021-02-01 criteria provided, single submitter research We identified the heterozygous GP1BA variant (NM_000173.5:c.344T>C, NP_000164.5:p.Leu115Pro) in a female individual affected with familial thrombocytopenia, and classified it as a VUS. Co-segregation analysis has now been performed which allows us to reclassify the variant as likely pathogenic. We have now tested the 4 siblings in this family, 2 of whom are affected and have the variant and 2 who are unaffected and do not have the variant. An affected cousin of theirs was tested at Cambridge, UK (by Sanger) and they are also heterozygous for this variant. Using the algorithm suggested by Jarvik and Browning (Am Jour Hum Gen 98, 1077-1081, June 2, 2016) we have calculated that probability of this variant co-segregating with disease and not being pathogenic as 0.016, and so have increased the strength of this evidence (PP1) to strong. This, along with PM2 and PP3, means that we can now classify this variant as "likely pathogenic".

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.